SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-009512
Filing Date
2023-05-12
Accepted
2023-05-12 08:13:48
Documents
15
Period of Report
2023-05-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrbo-20230511x8k.htm   iXBRL 8-K 48444
2 EX-99.1 nrbo-20230511xex99d1.htm EX-99.1 11468
3 GRAPHIC nrbo-20230511xex99d1001.jpg GRAPHIC 12776
  Complete submission text file 0001558370-23-009512.txt   293751

Data Files

Seq Description Document Type Size
4 EX-101.SCH nrbo-20230511.xsd EX-101.SCH 3267
5 EX-101.LAB nrbo-20230511_lab.xml EX-101.LAB 634
6 EX-101.PRE nrbo-20230511_pre.xml EX-101.PRE 10418
9 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20230511x8k_htm.xml XML 4873
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 23913290
SIC: 2834 Pharmaceutical Preparations